Profil
McDavid Stilwell worked as a Director of Business Development & Communications at GTx, Inc. from 2005 to 2012.
He then worked as the SVP of Corporate Communications & Investor Relations at Sangamo Therapeutics, Inc. After that, he worked as the VP of Communications & Business Development at Orexigen Therapeutics, Inc. from 2012 to 2016.
Currently, he is the Chief Financial Officer at Coherus BioSciences, Inc. starting from 2021 and ending in 2023.
Mr. Stilwell completed his undergraduate degree from St. John's College in 1993 and earned an MBA from Harvard Business School in 2005.
Anciens postes connus de McDavid Stilwell
| Sociétés | Poste | Fin |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Directeur Financier/CFO | 08/12/2023 |
| OREXIGEN THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2016 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Public Communications Contact | 01/01/2012 |
| SANGAMO THERAPEUTICS, INC. | Investor Relations Contact | - |
Formation de McDavid Stilwell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
St. John's College
St. John's College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















